Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Equillium, Inc. before investing.

In this article, we go over a few key elements for understanding Equillium, Inc.’s stock price such as:

• Equillium, Inc.’s current stock price and volume
• Why Equillium, Inc.’s stock price changed recently
• Upgrades and downgrades for EQ from analysts
• EQ’s stock price momentum as measured by its relative strength

About Equillium, Inc. (EQ)

Before we jump into Equillium, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

Want to learn more about Equillium, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Equillium, Inc..

Equillium, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Equillium, Inc.’s stock price was $2.200.

Equillium, Inc. is down 5.17% from its previous closing price of $2.320.

During the last market session, Equillium, Inc.’s stock traded between $2.175 and $2.370. Currently, there are approximately 96.28 million shares outstanding for Equillium, Inc..

Equillium, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Equillium, Inc. Stock Price History

Equillium, Inc.’s (EQ) price is currently down 31.25% so far this month.

During the month of July, Equillium, Inc.’s stock price has reached a high of $3.290 and a low of $2.175.

Over the last year, Equillium, Inc. has hit prices as high as $3.540 and as low as $0.370. Year to date, Equillium, Inc.’s stock is up 41.94%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Equillium, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there was 1 analyst who downgraded Equillium, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Equillium, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Equillium, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Equillium, Inc. (EQ) by visiting AAII Stock Evaluator.

Relative Price Strength of Equillium, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, Equillium, Inc. has a weighted four-quarter relative price strength of 57.70%, which translates to a Momentum Score of 99 and is considered to be Very Strong.

Want to learn more about how Equillium, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Equillium, Inc. Stock Price: Bottom Line

As of July 31, 2026, Equillium, Inc.’s stock price is $2.200, which is down 5.17% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Equillium, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.